MiNK Therapeutics (INKT) Stock Chart & Stock Price History $0.71 -0.01 (-1.39%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MiNK Therapeutics Stock Price Performance5 Day Performance-5.34%1 Month Performance-4.83%3 Month Performance-18.79%6 Month Performance-26.86%Year-To-Date Performance-33.74%1 Year Performance-31.17% Receive INKT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here INKT Stock Chart for Saturday, November, 2, 2024 INKT Chart by TradingView MiNK Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$0.71$0.71-0.70%$0.73$0.6825,719 shs$28.03 million10/31/2024$0.72$0.71-0.97%$0.72$0.6837,974 shs$28.23 million10/30/2024$0.75$0.72-3.71%$0.75$0.7213,594 shs$25.04 million10/29/2024$0.75$0.75-0.03%$0.75$0.7119,048 shs$26.00 million10/28/2024$0.71$0.75+5.69%$0.75$0.7120,493 shs$26.01 million10/25/2024$0.72$0.70-3.03%$0.72$0.7013,915 shs$24.38 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$0.71$0.72+2.61%$0.73$0.7126,872 shs$25.14 million10/23/2024$0.72$0.71-2.01%$0.73$0.7017,459 shs$24.50 million10/22/2024$0.71$0.72+1.41%$0.73$0.6916,783 shs$25.00 million10/21/2024$0.68$0.71+3.95%$0.72$0.6914,404 shs$24.66 million10/18/2024$0.70$0.68-2.29%$0.72$0.6720,726 shs$23.72 million10/17/2024$0.69$0.70+1.30%$0.70$0.6725,196 shs$24.28 million10/16/2024$0.67$0.69+3.76%$0.70$0.6724,226 shs$23.96 million10/15/2024$0.68$0.67-2.21%$0.70$0.6519,482 shs$23.09 million10/14/2024$0.67$0.68+1.34%$0.70$0.6726,157 shs$23.62 million10/11/2024$0.68$0.67-1.03%$0.70$0.6635,474 shs$23.30 million10/10/2024$0.68$0.68+0.15%$0.68$0.6523,227 shs$23.55 million10/09/2024$0.68$0.68-0.15%$0.68$0.6051,419 shs$23.51 million10/08/2024$0.71$0.68-4.52%$0.72$0.57588,421 shs$23.55 million10/07/2024$0.72$0.71-0.98%$0.74$0.718,007 shs$24.66 million10/04/2024$0.73$0.72-1.23%$0.76$0.7214,418 shs$24.90 million10/03/2024$0.75$0.73-2.55%$0.76$0.728,184 shs$25.21 million10/02/2024$0.74$0.75+1.36%$0.75$0.7311,874 shs$25.87 million10/01/2024$0.75$0.74-2.00%$0.77$0.7423,507 shs$25.53 million09/30/2024$0.75$0.75-0.31%$0.75$0.7415,750 shs$26.05 million09/27/2024$0.76$0.75-1.01%$0.75$0.7411,948 shs$26.13 million09/26/2024$0.76$0.76$0.77$0.7511,175 shs$26.39 million09/25/2024$0.74$0.76+2.67%$0.77$0.7517,477 shs$26.39 million09/24/2024$0.75$0.74-1.06%$0.77$0.748,828 shs$25.71 million09/23/2024$0.75$0.75-0.76%$0.77$0.746,480 shs$25.98 million09/20/2024$0.77$0.75-1.72%$0.77$0.7418,003 shs$26.18 million09/19/2024$0.74$0.77+3.65%$0.79$0.7227,099 shs$26.64 million09/18/2024$0.75$0.74-1.35%$0.76$0.7141,097 shs$25.70 million09/17/2024$0.75$0.75-0.25%$0.77$0.7513,313 shs$26.05 million09/16/2024$0.78$0.75-3.03%$0.79$0.7437,716 shs$26.12 million09/13/2024$0.76$0.78+1.85%$0.80$0.7511,344 shs$30.66 million09/12/2024$0.78$0.76-1.75%$0.79$0.7622,082 shs$26.44 million09/11/2024$0.78$0.78-1.22%$0.79$0.7624,187 shs$26.91 million09/10/2024$0.80$0.78-1.68%$0.81$0.7713,738 shs$31.02 million09/09/2024$0.79$0.80+1.23%$0.81$0.7717,899 shs$31.55 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024$0.79$0.79-0.22%$0.83$0.7744,741 shs$27.38 million09/05/2024$0.80$0.79-1.15%$0.80$0.7953,391 shs$27.44 million09/04/2024$0.82$0.80-2.52%$0.81$0.799,970 shs$27.76 million09/03/2024$0.81$0.82+1.22%$0.82$0.806,213 shs$28.47 million09/02/2024$0.81$0.81$0.81$0.7927,400 shs$28.13 million08/30/2024$0.79$0.81+2.53%$0.81$0.7920,983 shs$28.13 million08/29/2024$0.79$0.79-0.62%$0.80$0.7929,386 shs$27.44 million08/28/2024$0.82$0.79-3.01%$0.82$0.7963,097 shs$27.61 million08/27/2024$0.80$0.82+2.28%$0.82$0.8010,121 shs$28.46 million08/26/2024$0.82$0.80-2.28%$0.84$0.8012,279 shs$27.83 million08/23/2024$0.81$0.82+1.52%$0.84$0.7953,844 shs$28.48 million08/22/2024$0.84$0.81-3.75%$0.82$0.8044,889 shs$28.05 million08/21/2024$0.84$0.84+0.02%$0.86$0.8023,390 shs$29.14 million08/20/2024$0.84$0.84$0.84$0.8014,045 shs$29.14 million08/19/2024$0.81$0.84+3.59%$0.85$0.8132,872 shs$29.14 million08/16/2024$0.82$0.81-1.35%$0.85$0.8040,696 shs$28.13 million08/15/2024$0.84$0.82-2.26%$0.85$0.8118,109 shs$28.51 million08/14/2024$0.85$0.84-1.01%$0.87$0.8220,064 shs$29.17 million08/13/2024$0.84$0.85+1.63%$0.87$0.8155,415 shs$29.47 million08/12/2024$0.79$0.84+5.70%$0.84$0.7858,295 shs$29.00 million08/09/2024$0.82$0.79-3.89%$0.81$0.7947,017 shs$27.44 million08/08/2024$0.84$0.82-2.03%$0.85$0.8013,930 shs$28.55 million08/07/2024$0.85$0.84-1.06%$0.85$0.8040,547 shs$29.14 million08/06/2024$0.81$0.85+4.69%$0.85$0.8121,198 shs$29.45 million08/05/2024$0.87$0.81-7.22%$0.87$0.8189,316 shs$28.13 million08/02/2024$0.90$0.87-2.78%$0.89$0.8539,540 shs$30.32 million08/01/2024$0.94$0.90-4.47%$0.93$0.8754,940 shs$31.19 million Related Companies Celularity Stock Chart Elevation Oncology Stock Chart Atara Biotherapeutics Stock Chart Precision BioSciences Stock Chart Cellectis Stock Chart PyroGenesis Canada Stock Chart Senti Biosciences Stock Chart Benitec Biopharma Stock Chart AlloVir Stock Chart FibroBiologics Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
